| Systematic (IUPAC) name | |
|---|---|
| (6aR)-3-[(Z)-6-azidohex-2-enyl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 10761489 |
| Chemical data | |
| Formula | C22H29N3O2 |
| Mol. mass | 367.483 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
O-1238 is a drug which is a cannabinoid derivative that is used in scientific research. It is a partial agonist at the cannabinoid receptor CB1,[1] producing a maximal stimulation of 58.3%[2] with a Ki of 8.45nM.[3]
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)